What is a ventilation-perfusion (V/Q) mismatch and why does it cause desaturation after administration of albuterol (salbutamol) in a patient with asthma? | Rounds What is a ventilation-perfusion (V/Q) mismatch and why does it cause desaturation after administration of albuterol (salbutamol) in a patient with asthma? | Rounds
Loading...

What is a ventilation-perfusion (V/Q) mismatch and why does it cause desaturation after administration of albuterol (salbutamol) in a patient with asthma?

Medical Advisory Board
All articles are reviewed for accuracy by our Medical Advisory Board.

Educational purpose only · Not a substitute for professional judgment or the full text of guidelines and labels.

Article Review Status
Submitted
Under Review
Approved

Last updated: July 14, 2026 · View editorial policy

Ventilation–Perfusion (V/Q) Mismatch

Ventilation–perfusion (V/Q) mismatch is an imbalance between regional alveolar ventilation (airflow reaching alveoli) and regional pulmonary capillary perfusion (blood flow reaching alveoli). [1,2] This mismatch causes inefficient gas exchange, leading to arterial oxygen (PaO2) reduction and hypoxemia. [1,2]

Normal V/Q Matching and Gas Exchange Efficiency

Gas exchange depends on the regional coupling of ventilation to perfusion at the alveolar level. [3] When ventilation matches perfusion in each lung unit, alveolar oxygen tension more effectively reflects oxygen transfer from inspired air to blood. [3]

Mechanisms of V/Q Mismatch in Asthma

Asthma produces airflow obstruction that creates uneven alveolar ventilation across lung regions. [2] Some lung units become poorly ventilated relative to their blood flow, creating low-V/Q units that deliver blood that is relatively under-oxygenated. [2,3] Hypoxic pulmonary vasoconstriction can partially compensate by diverting perfusion away from poorly ventilated units, which improves V/Q matching. [3,4]

How Albuterol (Salbutamol) Can Worsen V/Q Matching

High-dose or rapidly delivered beta-agonist therapy can transiently worsen V/Q matching in acute asthma by decreasing hypoxic pulmonary vasoconstriction through pulmonary vasodilation. [5] This vasodilation increases perfusion to lung units that remain relatively poorly ventilated during ongoing airway obstruction. [5] The net effect is an increase in low-V/Q shunt-like physiology, which can cause a further acute fall in oxygen saturation despite bronchodilation. [5]

Clinical Manifestation: Desaturation After Beta-Agonist Administration

Desaturation after albuterol in asthma is consistent with an increase in the proportion of blood passing through low-V/Q lung units. [2,3] Arterial oxygenation typically improves when V/Q mismatch predominates, but beta-agonist–related perfusion redistribution can transiently negate that improvement in severe cases. [1,2,5]

Alternative Explanations to Consider in Severe Asthma

Ongoing bronchospasm can persist despite bronchodilator exposure, leaving ventilation uneven and maintaining low-V/Q units. [2] Administration technique can contribute to transient worsening of oxygenation in acute severe asthma through rapid delivery and physiologic effects of inhaled beta-agonists. [5]

Key Evidence Linking Beta-Agonists to Hypoxemia via V/Q Mismatch

A review of acute severe asthma describes evidence that salbutamol can worsen V/Q mismatch by causing pulmonary vasodilatation and increasing cardiac output, which can transiently increase V/Q mismatch enough to trigger critical desaturation. [5] Historical asthma practice-parameter material reports that nonselective beta-agonist exposure via inhalation can decrease arterial PO2 in asthmatic patients as a result of ventilation/perfusion mismatching despite improvement in airway obstruction. [6]

Practical Physiologic Summary

V/Q mismatch is the core mechanism linking unequal ventilation to hypoxemia in asthma. [2,3] Albuterol can worsen V/Q mismatch when pulmonary vasodilation increases perfusion to still-poorly ventilated alveoli, producing a transient, shunt-like worsening in oxygenation. [5]

Related Questions